this invention relates to a method for the treatment or prevention of osteoporosis in an individual suffering from increased bone turnover , said method comprising administering to said individual an effective amount of a therapeutically active compound , which is a selective estrogen receptor modulator of the triphenylalkene or triphenylalkane structure .